Tyzivumab

N/A

Report date: 2023/12/04 20:05:36

Base Information

Drug NameTyzivumab
Drug Alias NameTyzivumab - Tychan/WuXi BiologicsZika mAbZAb-FLEPTY-008
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionImmunomodulatorsEnvelope (E) protein inhibitors
TargetsEnvelope (E) protein
Therapy Area/IndicationsZika Virus Infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingapore
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTychanWuxi Biologics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTychan Pte Ltd
Active IndicationsN/A
Inactive IndicationsZika Virus Infection

Other Information

ATC CodeN/A
Related LinksN/A